Pro-Dex (PDEX)
NASDAQ:PDEX
Want to see PDEX full AI Analyst Report?
PDEX Stock Chart & Stats
$36.76
-$1.12(-2.15%)
At close: 4:00 PM EST
$36.76
-$1.12(-2.15%)
Day’s Range― - ―
52-Week Range$23.47 - $65.88
Previous CloseN/A
Volume17.72K
Average Volume (3M)29.60K
Market Cap
$202.80M
Enterprise Value$212.98M
Total Cash (Recent Filing)$10.98M
Total Debt (Recent Filing)$20.17M
Price to Earnings (P/E)10.0
Beta0.19
Next Earnings
Aug 20, 2026EPS Estimate
0.67Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3.70
Shares Outstanding3,192,759
10 Day Avg. Volume32,852
30 Day Avg. Volume29,604
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)3.92
Price to Sales (P/S)2.15
P/FCF Ratio-49.00
Enterprise Value/Market Cap1.05
Enterprise Value/Revenue2.85
Enterprise Value/Gross Profit10.27
Enterprise Value/Ebitda10.85
Forecast
1Y Price Target
$70.00Price Target Upside90.42% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Analyst ConfidenceAnalyst maintains a BUY rating and raises the 12-month price target to $52, reflecting confidence in the company’s strong growth potential.
Product DiversificationPro-Dex is diversifying its customer base and product lines by developing new devices, which is seen as a positive move.
Revenue GrowthPro-Dex reported fiscal Q2 2025 revenue of $16.8 million, a 33% increase year-over-year, exceeding estimates.
Bears Say
Operational ChallengesThe company experienced a large jump in backlog, with Q1 backlog rising to $57 million from $20 million in the previous quarter.
Pro-Dex News
PDEX FAQ
What was Pro-Dex’s price range in the past 12 months?
Pro-Dex lowest stock price was $23.47 and its highest was $65.88 in the past 12 months.
What is Pro-Dex’s market cap?
Pro-Dex’s market cap is $202.80M.
When is Pro-Dex’s upcoming earnings report date?
Pro-Dex’s upcoming earnings report date is Aug 20, 2026 which is in 85 days.
How were Pro-Dex’s earnings last quarter?
Pro-Dex released its earnings results on Apr 30, 2026. The company reported $1.2 earnings per share for the quarter, beating the consensus estimate of N/A by $1.2.
Is Pro-Dex overvalued?
According to Wall Street analysts Pro-Dex’s price is currently Undervalued.
Does Pro-Dex pay dividends?
Pro-Dex does not currently pay dividends.
What is Pro-Dex’s EPS estimate?
Pro-Dex’s EPS estimate is 0.67.
How many shares outstanding does Pro-Dex have?
Pro-Dex has 3,192,759 shares outstanding.
What happened to Pro-Dex’s price movement after its last earnings report?
Pro-Dex reported an EPS of $1.2 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3.55%.
Which hedge fund is a major shareholder of Pro-Dex?
Currently, no hedge funds are holding shares in PDEX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Pro-Dex Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$70.00 (90.42% Upside)
$70.00 (90.42% Upside)
Blogger Sentiment
Bullish
PDEX Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 14.1K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-12.43%
12-Months-Change
Fundamentals
Return on Equity
29.10%
Trailing 12-Months
Asset Growth
16.65%
Trailing 12-Months
Company Description
Pro-Dex
Pro-Dex, Inc. (PDEX) is a publicly traded company that specializes in the development and manufacture of innovative products for the medical and industrial sectors. The company focuses primarily on the production of precision-engineered devices and components, including surgical instruments, dental equipment, and robotic systems. Pro-Dex is known for its commitment to quality and technological advancement, providing solutions that enhance efficiency and safety in medical procedures and industrial applications.
PDEX Stock 12 Month Forecast
Average Price Target
$70.00
▲(90.42% Upside)
Technical Analysis
Utah Medical Products
―
Microbot Medical
―
REPRO-MED Systems
―
Sharps Technology, Inc.
―
Jin Medical International Ltd.
―
Ownership Overview
45.44% Insiders
7.25% Mutual Funds
5.24% Other Institutional Investors
34.71% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---